Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
2
Kicking Off MOPD 2026 With Lawrence Schachner, MD
3
The Intersection of Acne, Atopic Dermatitis, and Modern Skin Care
4
UCB Presents 3-Year BE HEARD Trial Results for Bimekizumab in Moderate-to-Severe HS
5







